Effect of 6-O-sulfonate hexosamine residue on anticoagulant activity of fully O-sulfonated glycosaminoglycans

Glycoconjugate Journal

Volumn 17, Issue 6, 2000, Pages 393-399

  Toida, T ^a   Suzuki, A ^a   Nakajima, K ^a   Chaidedgumjorn, A ^a   Imanari, T ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Anticoagulant activity; Chemical oversulfonation; Glycosaminoglycans; Selective 6 O desulfonation

Indexed keywords

ACETAMIDE DERIVATIVE; CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HEXOSAMINE; HYALURONIC ACID; SULFONIC ACID DERIVATIVE;

ANTICOAGULATION; ARTICLE; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ANTICOAGULANTS; FACTOR XA; GLYCOSAMINOGLYCANS; GLYCOSYLATION; HUMANS; IMIDOESTERS; MAGNETIC RESONANCE SPECTROSCOPY; PROTHROMBIN; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS; TRIMETHYLSILYL COMPOUNDS;

EID: 0034463962     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007108131223     Document Type: Article

References (32)

1. Cytodifferentiation and proteoglycan biosynthesis
2. Structure and function of heparan sulphate proteoglycans
3. Immunology of chondroitin/dermatan sulfate
4. Cell-surface glycosaminoglycans
5. Hyaluronan: Its nature, distribution, functions and turnover
6. Structural features and binding properties of chondroitin sulfates, dermatan sulfate, and heparan sulfate
7. Dermatan sulfate as a potential therapeutic agent
8. Structure and biological activity of heparin
9. Heparin oligosaccharides-New analogs development and applications
10. Heparinoids: Structure, biological activities and therapeutic applications
11. More to "heparin" than anticoagulation
12. New methodologies in heparin structure analysis and the generation of LMW heparins
13. Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide
14. Antigens involved in heparin-induced thrombocytopenia
15. Simultaneous binding of heparin and platelet factor-4 to platelets: Further insights into the mechanism of heparin-induced thrombocytopenia
16. Low molecular weight heparins in clinical practice: Unsolved or partially solved problems
17. Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation
18. Preparation and anticoagulant activity of fully O-sulphonated glycosaminoglycans
19. NMR solution conformation of heparin-derived hexasaccharide
20. Structural diversity of dermatan sulphate in procine dermis
21. Highly sulfated dermatan sulfates from Ascidians. Structure versus anti-coagulant activity of these glycosaminoglycans
22. A novel regioselective desulfation of polysaccharide sulfates: Specific 6-O-desulfation with N,O-bis(trimethylsilyl)acetamide
23. Conformational equilibria of alpha-L-iduronate residues in disaccharides derived from heparin
24. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides
25. Common conditions for high-performance liquid chromatographic microdetermination of aldoses, hexosamines, and sialic acids in glycoproteins
26. Amino acid residues of heparin cofactor II required for stimulation of thrombin inhibition by sulphated polyanions
27. Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives
28. The low molecular weight heparin, enoxaparin, limits infarct size at reperfusion in the dog
29. Determination of human urinary hyaluronic acid, chondroitin sulphate and dermatan sulphate as their unsaturated disaccharides by high-performance liquid chromatography
30. High resolution proton nuclear magnetic resonance studies on chondroitin sulfates
31. Preparation and biological activity of N-sulfonated chondroitin and dermatan sulfate derivatives